The most award winning
healthcare information source.
TRUSTED FOR FOUR DECADES.
Yam M. Seen but not heard: Battered women’s perceptions of the ED experience. J Emerg Nurs 2000; 26:464-470.
Battered women are dissatisfied with the care they receive in the ED, according to this study from the department of nursing at St. Peter’s College in Englewood Cliffs, NJ. Five women who had been to the ED for abuse-related injuries in the previous 12 months were interviewed by the researcher. The women reported difficulty in disclosing the abuse to staff. They also wanted to be interviewed privately, have compassion expressed by staff, and to have an advocate available in the ED so they could explore all their options, according to the study’s findings.
The researcher suggests the following:
• having on-site battered women’s advocates to augment the services provided by ED staff;
• providing frequent staff education to ensure that new staff are adequately trained and the skills of staff are maintained;
• encouraging staff to examine their beliefs about abuse and inviting advocates to training sessions to discuss issues with staff members.
Plint AC, Osmond MH, Klassen TP. The efficacy of nebulized racemic epinephrine in children with acute asthma: A randomized double-blind trial. Acad Emerg Med 2000; 7:1,097-1,103.
Nebulized epinephrine is not a better treatment than salbutamol in children 1 to 17 years with mild to moderate acute asthma, according to this study from the Department of Pediatrics at the University of Ottawa in Ontario and the University of Alberta in Edmonton, Alberta, Canada.
Both medications appear to be equally efficacious, but the following make salbutamol the treatment of choice in children with known asthma, say the researchers:
• Racemic epinephrine costs two to 10 times as much as salbutamol.
• Salbutamol is the same medication that most parents have at home and are comfortable using.
• Salbutamol has a good safety profile and has been widely used.
"We recommend that the current use of aerosolized ß2 agonists in known asthmatic patients should not change," write the researchers.